Gender Dysphoria Clinical Trial
Official title:
Effectiveness of Speech Therapy in Trans Women.
Verified date | December 2023 |
Source | University Ghent |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
One of the greatest hurdles in the transition of transgender persons is that voice, speech and communication are not congruent with the desired gender. Since hormone treatment does not affect the voice in male-to-female transgender persons (trans women), speech therapy is the treatment of choice to develop a more feminine communication. Speech therapy must focus on aspects of communication that play an important role in listener perceptions of the speakers gender. Results of a systematic review and meta-analysis showed that those aspects are primarily fundamental frequency of the voice and resonance. However, effectiveness studies of speech interventions in transwomen are extremely limited and show methodological limitations. The purpose of this project is to investigate the short-term and longterm impact of speech exercises for pitch and resonance on (a) acoustic voice characteristics, (b) listener perceptions of femininity using a visual analogue scale and binary gender identification (male versus female voice), and (c) self-perception and psychosocial functioning in trans women using a randomized sham-controlled trial and cross-over design.
Status | Completed |
Enrollment | 78 |
Est. completion date | March 30, 2023 |
Est. primary completion date | March 30, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - established diagnose and gender identity confirmed by the gender team, - aged between 18 and 70 years, - self-reported normal hearing, - native Dutch speaker, - under hormonal treatment (confirmed by blood analysis), - female gender role, perceived as male speaker at the beginning of the therapy by the investigators - speaking fo within the male or ambiguous zone (<180Hz). Exclusion Criteria: - history of neurological disorders, previous phonosurgery or speech therapy - pathology of the vocal folds (observed by videolaryngostroboscopic examination of the vocal cords), - smokers. - to form a homogeneous study population gender non-binary persons will not be included in this study. |
Country | Name | City | State |
---|---|---|---|
Belgium | Evelien D'haeseleer | Gent |
Lead Sponsor | Collaborator |
---|---|
University Ghent |
Belgium,
Carew L, Dacakis G, Oates J. The effectiveness of oral resonance therapy on the perception of femininity of voice in male-to-female transsexuals. J Voice. 2007 Sep;21(5):591-603. doi: 10.1016/j.jvoice.2006.05.005. Epub 2006 Jul 5. — View Citation
Dacakis G. Long-term maintenance of fundamental frequency increases in male-to-female transsexuals. J Voice. 2000 Dec;14(4):549-56. doi: 10.1016/s0892-1997(00)80010-7. — View Citation
Gelfer MP, Mikos VA. The relative contributions of speaking fundamental frequency and formant frequencies to gender identification based on isolated vowels. J Voice. 2005 Dec;19(4):544-54. doi: 10.1016/j.jvoice.2004.10.006. — View Citation
Gelfer MP, Tice RM. Perceptual and acoustic outcomes of voice therapy for male-to-female transgender individuals immediately after therapy and 15 months later. J Voice. 2013 May;27(3):335-47. doi: 10.1016/j.jvoice.2012.07.009. Epub 2012 Oct 22. — View Citation
Leung Y, Oates J, Chan SP. Voice, Articulation, and Prosody Contribute to Listener Perceptions of Speaker Gender: A Systematic Review and Meta-Analysis. J Speech Lang Hear Res. 2018 Feb 15;61(2):266-297. doi: 10.1044/2017_JSLHR-S-17-0067. — View Citation
Soderpalm E, Larsson A, Almquist SA. Evaluation of a consecutive group of transsexual individuals referred for vocal intervention in the west of Sweden. Logoped Phoniatr Vocol. 2004;29(1):18-30. doi: 10.1080/14015430310021618. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Acoustics: change in speaking fundamental frequency | Median Speaking fo, fo upper limit (pc95), fo lower limit (pc25) | pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year) | |
Primary | Acoustics: change in formant frequencies | Median Formant Frequencies F1-F5 of the vowels /a/, /i/, /u/ | pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year) | |
Primary | Change in listeners perceptions | masculinity/femininity ratings (using a VAS) and gender identification | pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year) | |
Primary | Change in self-assessment | Trans women voice questionnaire | pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year) | |
Secondary | Change in Dysphonia Severity Index | The DSI is a multiparametric approach designed to establish an objective and quantitative correlate of the perceived vocal quality [19]. It is based on a weighted combination of 4 voice parameters: maximum phonation time (MPT, s), highest frequency (F-high, Hz), lowest intensity (I-low, dB) and jitter (%). The DSI is constructed as 0.13 MPT + 0.0053 F-high - 0.26 I-low - 1.18 jitter +12.4. The index ranges from -5 to +5 for severely dysphonic to normal voices but values higher than +5 are possible in subjects with excellent vocal capacities. | pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year) | |
Secondary | Change in Acoustic Voice Quality Index | The AVQI is a robust and valid method to quantify the severity of overall dysphonia based on both continuous and sustained vowel recordings [20]. This multiparameter index consists of a weighted combination of 6 voice parameters: smoothed cepstral peak prominence (CPPS), harmonics-to-noise ratio (HNR), shimmer local (SL), shimmer local dB (SLdB), general slope of the spectrum (slope) and tilt of the regression line through the spectrum (tilt). The formula is constructed as 9.072 - 0.245 × CPPs - 0.161 × HNR - 0.470 × SL + 6.158 × SLdB - 0.071 × Slope - 0.170 × Tilt and ranges from 0 to 10. The higher the score of the AVQI, the worse is the overall vocal quality. | pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year) | |
Secondary | Change in Voice Range Profile | The frequency and intensity range of the voices will be measured with the Voice Range Profile software of the Computerized Speech lab of Kay following the procedure of Heylen et al. | pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06098781 -
Gynaecological Gender-affirming Surgeries
|
||
Recruiting |
NCT04064671 -
ZEPHYR: A Study Evaluating Surgical Outcome After Implantation of the Zephyr ZSI 475 FTM Inflatable Penile Implant in the Neophallus After Female-to-male Sex Reassignment Surgery
|
||
Completed |
NCT03602222 -
An LGBT-Competency Program for Mental Health Professionals in Romania
|
N/A | |
Completed |
NCT04195659 -
Chest Dysphoria in Transmasculine Spectrum Adolescents
|
||
Not yet recruiting |
NCT05903911 -
Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
|
N/A | |
Not yet recruiting |
NCT04265885 -
Gender Dysphoria and Transition
|
||
Not yet recruiting |
NCT04160364 -
Gender Dysphoria in Children and Adolescents : Parents' Perspectives
|
||
Recruiting |
NCT06245681 -
Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content
|
||
Active, not recruiting |
NCT05489159 -
Sleep and IR in Transgender Adolescents
|
||
Recruiting |
NCT04736797 -
Transition in Transgender
|
||
Recruiting |
NCT04979338 -
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
|
Phase 3 | |
Recruiting |
NCT05829928 -
Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy
|
||
Recruiting |
NCT04993469 -
Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery
|
N/A | |
Recruiting |
NCT05884307 -
Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
|
N/A | |
Recruiting |
NCT05883553 -
Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients.
|
N/A | |
Completed |
NCT04290286 -
i2TransHealth: Interdisciplinary, Internet-based Trans Health Care
|
N/A | |
Terminated |
NCT03078829 -
The Relation of GnRH Treatment to QTc Interval in Transgender Females
|
||
Recruiting |
NCT05649605 -
Early Mental Response - The EMRE Study
|
N/A | |
Recruiting |
NCT05204732 -
Acoustic and Perceptual Effects of Intonation Training in Gender Diverse People
|
N/A | |
Recruiting |
NCT06291675 -
Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content
|